Jiangsu Hengrui Medicine Co., Ltd. develops, manufactures, and markets a variety of medicines and medicine packing materials. The Company's products include anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.

Announcement on Obtaining the Notice of Approval for Drug Clinical Trials

Indicative Announcement on Achievement of Conditions for Unlocking Some Shares and Expiration of the 2nd Lock-up Period under 2022 Employee Stock Ownership Plan

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jiangsu Hengrui Medicine (600276 CH)

Announcement on Obtaining the Notice of Approval for Drug Clinical Trials

Announcement on Obtaining the Notice of Approval for Drug Clinical Trials

Indicative Announcement on Achievement of Conditions for Unlocking Some Shares and Expiration of the 2nd Lock-up Period under 2022 Employee Stock Ownership Plan

Announcement on Obtaining the Notice of Approval for Drug Clinical Trials

Report for Q3 2024

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)